EUVIMEDEUVIMED entdecken
Crossref

The Proton‐Activated Chloride Channel Inhibits SARS‐CoV‐2 Spike Protein‐Mediated Viral Entry Through the Endosomal Pathway

Nicholas Koylass, Jaiprasath Sachithanandham, James Osei-Owusu, Kevin Hong Chen, Henry Yi Cheng, Andrew Pekosz, Zhaozhu Qiu iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Nicholas Koylass und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Endosomes, Spike Glycoprotein, Coronavirus, SARS-CoV-2, Virus Internalization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 binds to its obligatory receptor, angiotensin‐converting enzyme 2 (ACE2) and capitalizes on decreasing endosomal acidity and cathepsin‐mediated spike protein cleavage to enter cells. Endosomal acidification is driven by V‐ATPase which pumps protons (H + ) into the lumen. The driving force for H + is maintained by the import of chloride (Cl − ) which is mediated by intracellular CLC transporters. We have recently identified the Proton‐Activated Chloride (PAC) channel as a negative regulator of endosomal acidification. PAC responds to low pH and releases Cl − from the lumen to prevent endosomal hyperacidification. However, its role in SARS‐CoV‐2 viral entry remains unexplored. Here, we show that overexpressing the PAC channel in ACE2 expressing HEK 293T cells markedly inhibited SARS‐CoV‐2 spike‐mediated viral entry. Several lines of evidence suggest that this effect was due to the suppression of the endosomal entry pathway. First, the abilities of PAC to regulate endosomal acidification and inhibit pseudoviral entry were both dependent on its endosomal localization and channel activity. Second, the inhibitory effect on viral entry was similar to the suppression mediated by E64‐d, a cathepsin inhibitor, while no major additive effect for both treatments was observed. Third, this inhibition was also attenuated in cells expressing TMPRSS2, which provides an alternative entry pathway through the cell surface. Importantly, PAC overexpression also inhibited the number and size of plaques formed by two live SARS‐CoV‐2 isolates (B.1 and Omicron XBB.1.16) in Vero E6 cells. Altogether, our data indicates that PAC plays a vital role in inhibiting SARS‐CoV‐2 viral entry and identifies this endosomal channel as a potential novel target against the infection of SARS‐CoV‐2 and other viruses, which rely on the endosomal pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndosomesSpike Glycoprotein, CoronavirusSARS-CoV-2Virus InternalizationChloride ChannelsCOVID-19HumansHEK293 CellsAngiotensin-Converting Enzyme 2Hydrogen-Ion ConcentrationVero CellsAnimalsProtonsChlorocebus aethiops

Stichwörter der Autor:innen

TMEM206cathepsinendosomeproton activated chloride channel (PAC)severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)transmembrane serine protease 2 (TMPRSS2)

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Chloride ChannelsAngiotensin-Converting Enzyme 2ACE2 protein, humanProtons

Autor:innen und Institutionen

  • Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Zhaozhu Qiu

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Koylass, N., Sachithanandham, J., Osei-Owusu, J., Chen, K. H., Cheng, H. Y., Pekosz, A., & Qiu, Z. (2025). The Proton‐Activated Chloride Channel Inhibits SARS‐CoV‐2 Spike Protein‐Mediated Viral Entry Through the Endosomal Pathway. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70063

Vancouver

Koylass N, Sachithanandham J, Osei-Owusu J, Chen KH, Cheng HY, Pekosz A, et al. The Proton‐Activated Chloride Channel Inhibits SARS‐CoV‐2 Spike Protein‐Mediated Viral Entry Through the Endosomal Pathway. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70063

BibTeX
@article{Koylass2025,
  author = {Koylass, Nicholas and Sachithanandham, Jaiprasath and Osei-Owusu, James and Chen, Kevin Hong and Cheng, Henry Yi and Pekosz, Andrew and Qiu, Zhaozhu},
  title = {The Proton‐Activated Chloride Channel Inhibits SARS‐CoV‐2 Spike Protein‐Mediated Viral Entry Through the Endosomal Pathway},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70063}
}
Kostenlos starten →